21
TITLE: Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel COMT inhibitor, during the first administration to healthy male subjects  Full Text
AUTHORS: Nunes, T; F Rocha; Pinto, R ; Machado, R; Wright, L; Falcao, A; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2012, SOURCE: 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 19
INDEXED IN: WOS
IN MY: ORCID
23
TITLE: Evaluation of Eslicarbazepine Acetate on Cardiac Repolarization in a Thorough QT/QTc Study
AUTHORS: Vaz da Silva, M ; Nunes, T; Almeida, L; Gutierrez, MJ; Litwin, JS; Soares da Silva, P ;
PUBLISHED: 2012, SOURCE: JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 52, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 19
IN MY: ORCID
26
29
TITLE: Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitor
AUTHORS: Luis Almeida; Ana I Loureiro; Manuel Vaz da Silva ; Leonel Torrao; Joana Maia; Carlos Fernandes Lopes; Amilcar Falcao ; Bruno Igreja; Lyndon Wright; Patricio Soares da Silva ;
PUBLISHED: 2010, SOURCE: CURRENT MEDICAL RESEARCH AND OPINION, VOLUME: 26, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
30
TITLE: Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects  Full Text
AUTHORS: Almeida, L; Nunes, T; Sicard, E; F Rocha; Falcao, A; S Brunet; Lefebvre, M; Soares da Silva, P ;
PUBLISHED: 2010, SOURCE: ACTA NEUROLOGICA SCANDINAVICA, VOLUME: 121, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 32
IN MY: ORCID
Page 3 of 7. Total results: 70.